Remdesivir administered despite toxic and unsuccessful

immagine.png

Source image

On October 8, 2020, Remdesivir drug company, Gilead, signed an agreement to provide the European Union with its drug as a treatment for COVID-19, a deal potentially worth over $ 1 billion. Two weeks later, on October 22, the United States Food and Drug Administration (FDA) approved remdesivir for use against the SARS-CoV-2 coronavirus pandemic in the United States, the first drug to receive such status.

The decision baffled scientists who had closely observed clinical trials of remdesivir over the past 6 months and who had many questions about the effectiveness of remdesivir. At best, a large, well-designed study found that remdesivir modestly reduced recovery time from COVID-19 in hospitalized patients with severe illness. Some smaller studies found no treatment impact on the disease, no benefit. Then, on October 15, news came decidedly unfavorable for Gilead - the fourth and largest controlled study revealed what some believed was a coup de grâce: the World Health Organization's (WHO) Solidarity study showed that remdesivir did not reduce mortality or time to recovery for COVID patients.

Dr. Anthony Fauci said in March 2020 (1) that Remdesivir was the only drug approved for the treatment of COVID-19 (prior to the approval of the FDA in October of the same year). Too bad that Remdesivir had already been used in an African study to treat Ebola in the Republic of Congo with absolutely disappointing results and Fauci was aware of this.

In March 2022, Pennsylvania Senator Doug Mastriano held a panel discussing Covid-19, treatments and related topics. Guest speakers included Dr. Peter McCoullough, Attorney Thomas Renz, Steve Kirsch and Dr. Bryan Ardis, among others.
Dr. Ardis pointed out that the other clinical trials for Ebola, which had much higher success rates and lower lethality rates, had been conducted with mixtures of monoclonal antibodies (2). The same ones who were highly put off by the mainstream narrative during the height of the COVID-19 pandemic.

Dr Bryan Ardis said:

Anthony Fauci used this drug to mass murder a whole group of innocent Americans. Then as he went on TV every night he told us that people were dying in droves from a virus, when in fact most of them were being poisoned to death with remdesivir. And so he needed this. They needed deaths so that American society would fear the virus and then volunteer for the vaccine.

Ardis said Fauci decided to have remdesivir injected into the veins of every COVID-19 patient in New York hospitals from March to April 2020, leading to the deaths of thousands of people in the state during that two-month period.

They called it a clinical trial and they were injecting remdesivir into these people and these people were dying in huge quantities. And then the deaths were attributed to the lethal virus when in fact they were dying mainly from remdesivir poisoning.

Ardis announced that probably 30% of people treated with remdesivir will die from multiple organ failure, including acute kidney failure, which could lead to pulmonary edema or fluid accumulation in the lungs. He also took note of the 850,000 dead Americans and 630,000 dead Brazilians who were treated with remdesivir.

According to an April 2020 article in Biospace (3), "About 25% of patients receiving [Remdesivir] have severe side effects, including multi-organ dysfunction syndrome, septic shock, acute kidney injury and low blood pressure. Another 23% showed evidence of liver damage in laboratory tests ”.

Ending clinical trials of Remdesivir early and choosing instead to go ahead with administration to the majority of hospitalized COVID-19 patients essentially limits the ability of researchers to collect more data that the drug saves lives.

Yet Fauci continued to push for its use.

Fauci pushed it so hard that he even criticized a peer-reviewed Chinese study published in The Lancet) that he claimed the drug failed to show improvement in COVID-19 patients. Fauci called that study "underpowered" and "not an adequate study".

In October 2021, a study published in the Cardiovascular Toxicology Journal, "Potential Cardiotoxic Effects of Remdesivir on Cardiovascular System: A Literature Review" (4) showed that remdesivir is toxic, has cardiotoxic effects. It actually kills heart cells and can lead to cardiac arrest and complete heart block. The journal even states that the cardiotoxicity or cardiac toxicity of remdesivir is far worse than the cardiotoxic effects of chloroquine.

(1): https://www.science.org/content/article/very-very-bad-look-remdesivir-first-fda-approved-covid-19-drug

(2): https://www.redvoicemedia.com/2022/04/dr-bryan-ardis-says-the-covid-bombshell-isnt-about-the-water-but-the-snake-venom-video/

(3): https://www.biospace.com/article/data-from-gilead-s-compassionate-use-of-remdesivir-for-covid-19-looks-promising/

(4): https://link.springer.com/article/10.1007/s12012-021-09703-9